P
Patricia E. Taylor
Researcher at New York Blood Center
Publications - 37
Citations - 5834
Patricia E. Taylor is an academic researcher from New York Blood Center. The author has contributed to research in topics: Hepatitis B vaccine & Hepatitis B virus. The author has an hindex of 26, co-authored 37 publications receiving 5759 citations. Previous affiliations of Patricia E. Taylor include University of Alabama.
Papers
More filters
Journal ArticleDOI
Outcomes among 562 Recipients of Placental-Blood Transplants from Unrelated Donors
Pablo Rubinstein,Carmelita Carrier,Andromachi Scaradavou,Joanne Kurtzberg,John W. Adamson,Anna Rita Migliaccio,Richard L. Berkowitz,Michael F. Cabbad,Dobrila Nl,Patricia E. Taylor,Richard E. Rosenfield,Cladd E. Stevens +11 more
TL;DR: Placental blood is a useful source of allogeneic hematopoietic stem cells for bone marrow reconstitution and is associated with the severity of GVHD, type of leukemia, and stage of the disease.
Journal ArticleDOI
Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution.
Pablo Rubinstein,Ludy Dobrila,Richard E. Rosenfield,John W. Adamson,Giovanni Migliaccio,Anna Rita Migliaccio,Patricia E. Taylor,Cladd E. Stevens +7 more
TL;DR: Almost all the hematopoietic colony-forming cells present in PCB units can be recovered in a uniform volume of 20 ml by using rouleaux formation induced by hydroxyethyl starch and centrifugation to reduce the bulk of erythrocytes and plasma and, thus, concentrate leukocytes.
Journal ArticleDOI
Hepatitis c virus infection in post-transfusion hepatitis - an analysis with first - and second - generation assays
R D Aach,Cladd E. Stevens,F B Hollinger,J W Mosley,D. A. Peterson,Patricia E. Taylor,R. G. Johnson,L. H. Barbosa,George J. Nemo +8 more
TL;DR: Two first-generation enzyme-linked immunoassays are used to test for anti-HCV antibodies in serum samples collected between 1976 and 1979 in the Transfusion-Transmitted Viruses Study and 111 of the 115 patients in whom post-transfusion non-A, non-B hepatitis developed were anti- HCV-negative.
Journal ArticleDOI
Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy.
Cladd E. Stevens,Harvey J. Alter,Patricia E. Taylor,Edith A. Zang,Edward J. Harley,Wolf Szmuness +5 more
TL;DR: This study did not demonstrate the efficacy of the vaccine in a population of patients receiving dialysis in whom both the rate of antibody response to hepatitis B vaccine and the viral attack rate were low, and other measures to control transmission of hepatitis B virus in dialysis units must be continued.
Journal ArticleDOI
Hepatitis B vaccine in medical staff of hemodialysis units: efficacy and subtype cross-protection.
Wolf Szmuness,Cladd E. Stevens,Edward J. Harley,Edith A. Zang,Harvey J. Alter,Patricia E. Taylor,Anita De Vera,George T. S. Chen,Aaron Kellner +8 more
TL;DR: The data confirm the efficacy of the vaccine and demonstrate subtype cross-protection and the virus was of the ay subtype in 81 per cent of the hepatitis events.